ArticleParasites & vectors2026
Detection of dengue virus serotype 2 in local Aedes aegypti populations, Madeira Island, Portugal, 2025.
Article in Parasites & vectors, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
16 authors.
Funding
Abstract
backgroundSince 2010, dengue virus (DENV) has caused sporadic outbreaks across Europe, namely in Croatia, Spain, France, Italy and the Portuguese island of Madeira. Aedes aegypti mosquito is established in the Autonomous Region of Madeira, and along the eastern Black Sea coast of Cyprus. In Madeira Island, an outbreak of DENV serotype 1 occurred between 2012 and 2013, resulting in 1080 confirmed cases. Despite ongoing entomological surveillance, no further local transmission was detected in the following decade.
methodsIn January 2025, following two suspected dengue cases on Madeira Island, increased entomological surveillance efforts were implemented to confirm a local event transmission of DENV. A network of mosquito traps was complemented by targeted surveillance using 17 BG-PRO traps positioned in the vicinity of suspected human cases. Daily collections of adult A. aegypti, collected from 10 January to 31 March 2025, were screened by reverse transcription polymerase chain reaction (RT-PCR) for Aedes-borne viruses in the reference laboratory. Viral sequencing was performed using target enrichment and bioinformatics with INSaFLU-TELEVIR. The climate-driven suitability for dengue transmission by A. aegypti was also investigated. Serological and molecular tests were conducted on samples from suspected human cases.
resultsOut of 80 analysed A. aegypti pools (N = 393 mosquitoes), 1 pool, with 9 mosquitoes collected near the home of suspected human cases, tested positive for DENV. The dengue whole genome sequence from this sample was determined and classified as DENV-2 lineage 2II_F.1.1.3. The same virus was retrospectively confirmed in one of the clinical cases. Analysis of mosquito abundance and climate data confirmed the occurrence of this local transmission event during a period of low mosquito abundance and low climatic suitability.
conclusionsHere, we report an in-depth analysis of a local dengue transmission event that occurred in Funchal, the capital of Madeira Island, in January 2025, with whole-genome evidence of DENV-2II_F.1.1.3 in field-caught A. aegypti mosquitoes. Retrospective analysis confirmed the presence of the same virus in one of the two clinical cases, establishing a direct link between human and mosquito infections, and highlighting the risk of off-season arboviral introductions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.